Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma
Author(s) -
Abbott Rebecca C,
Verdon Daniel J,
Gracey Fiona M,
HughesParry Hannah E,
Iliopoulos Melinda,
Watson Katherine A,
Mulazzani Matthias,
Luong Kylie,
D’Arcy Colleen,
Sullivan Lucy C,
Kiefel Ben R,
Cross Ryan S,
Jenkins Misty R
Publication year - 2021
Publication title -
clinical and translational immunology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.321
H-Index - 34
ISSN - 2050-0068
DOI - 10.1002/cti2.1317
Subject(s) - chimeric antigen receptor , glioblastoma , antigen , chemistry , cancer research , microbiology and biotechnology , virology , biology , immunology , immunotherapy , cancer , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom